title: [Correlation between hepatitis C virus (HVC) RNA and anti-HVC antibodies in a hemodialysis population].
abstract: Polymerase chain reaction (PCR) was applied to detect HCV-RNA in 75 hemodialyzed patients. Anti-HCV status was determined by ELISA-2 and by RIBA-2 for reactive samples by ELISA. ALT levels were monthly determined during the year preceding the end of the study. For 60 patients, anti-HCV serology was known since 1989 and 39 of them were tested for the presence of HCV-RNA at least four times during the 2 preceding years. The 9 patients who were negative for anti-HCV antibodies were negative by PCR. Of the 7 patients with an indeterminate profile by RIBA-2, 3 were positive by PCR: 1/1 with C-33c band only and 2/6 with C22-3 band only. Of the 59 patients reactive by RlBA-2, 57 were HCV-RNA positive. Of the 2 HCV-RNA negative patients, one had been PCR positive before interferon therapy. Of the 38 patients without acute hepatitis tested by PCR on 5 successive samples, all the specimens of 11 and 23 patients were HCV-RNA negative and HCV-RNA positive respectively. In 4 patients, a transient viremia was observed. The group of HCV-RNA positive patients had mean ALT levels greater than those who were negative. A correlation was established between HCV infection and both the time on dialysis and the number of blood transfusions. A high concordance (97%) was observed between antibodies to HCV and HCV-RNA.
authors.affiliation: Institut National de Transfusion Sanguine, Paris, France.
authors.forename: F
authors.initials: F
authors.lastname: Bouchardeau
authors.forename: P
authors.initials: P
authors.lastname: Chauveau
authors.forename: N
authors.initials: N
authors.lastname: Le Marrec
authors.forename: I
authors.initials: I
authors.lastname: Réach
authors.forename: C
authors.initials: C
authors.lastname: Naret
authors.forename: A
authors.initials: A
authors.lastname: Girault
authors.forename: M
authors.initials: M
authors.lastname: Zamroud
authors.forename: B
authors.initials: B
authors.lastname: Zins
authors.forename: P
authors.initials: P
authors.lastname: Finetti
authors.forename: A M
authors.initials: AM
authors.lastname: Couroucé
mesh_terms: D000328:Adult; D000368:Aged; D000410:Alanine Transaminase / Q000097:blood; D001483:Base Sequence; D015415:Biomarkers / Q000097:blood; D005260:Female; D016174:Hepacivirus / Q000235:genetics / Q000276:immunology* / Q000302:isolation & purification; D006508:Hepatitis Antibodies / Q000097:blood*; D006526:Hepatitis C / Q000097:blood / Q000201:enzymology / Q000276:immunology* / Q000635:transmission; D018937:Hepatitis C Antibodies; D006801:Humans; D008297:Male; D008875:Middle Aged; D008969:Molecular Sequence Data; D016133:Polymerase Chain Reaction; D012367:RNA, Viral / Q000097:blood*; D006435:Renal Dialysis / Q000009:adverse effects; D013997:Time Factors; D065227:Transfusion Reaction; D014766:Viremia / Q000276:immunology* / Q000382:microbiology
chemical_list: D015415:Biomarkers; D006508:Hepatitis Antibodies; D018937:Hepatitis C Antibodies; D012367:RNA, Viral; D000410:Alanine Transaminase